[PDF] Top 20 Quantitative EEG Changes in Patients with Parkinson’s Disease during Therapy with Rasagiline
Has 10000 "Quantitative EEG Changes in Patients with Parkinson’s Disease during Therapy with Rasagiline" found on our website. Below are the top 20 most common "Quantitative EEG Changes in Patients with Parkinson’s Disease during Therapy with Rasagiline".
Quantitative EEG Changes in Patients with Parkinson’s Disease during Therapy with Rasagiline
... study. Changes in d2 test scores between visits 1, 2 and 3 were analysed using ANOVA with a repeated measures ...data. EEG data are not normally distributed, therefore, the non-parametric sign test was ... See full document
14
Adjunctive therapy in Parkinson's disease: the role of rasagiline
... Parkinson’s Disease Rating Scale (UPDRS) ...404 patients with early PD, and randomized patients to placebo or rasagiline 1 mg or 2 mg per ...371 patients completed this half of the ... See full document
10
Comparison of Quantitative EEG Indices of the Patients with Alzheimer and Parkinson
... Alzheimer Disease (AD) and Parkinson’s disease Dementia (PDD) both affect the people and have severe psychological ...Parkinson’s disease dementia is observed among 30% of these patients ... See full document
5
Pain management in patients with Parkinson's disease: challenges and solutions
... Music is a universal art form that exists in every culture in the world. Music may also be a means by which individuals can cope with emotional conflicts and increase self-awareness. Music has been shown to induce ... See full document
11
Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
... combination therapy with levodopa 200–300 mg/d + rasagiline 1 mg/d (n=19) with levodopa 200–300 mg/d alone (n=19) in the treatment of sleep disorders in patients with idiopathic ...in patients ... See full document
6
Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
... adjunctive therapy with tolcapone (100 mg tid; n = 355) vs placebo (n = 342) in patients with early Parkinson’s disease treated with ...levodopa. Patients were assessed for effi cacy (UPDRS) ... See full document
6
The role of deep brain stimulation in Parkinson’s disease: an overview and update on new developments
... Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of neuronal dopamine production in the ...the disease progresses, more continuous delivery of therapy is ... See full document
10
The role of rasagiline in the treatment of Parkinson’s disease
... (Parkinson’s Rasagiline: Efficacy and Safety in the Treatment of “Off ”) was a randomized, placebo-controlled, double-blind trial of subjects with advanced PD with motor ...of rasagiline as adjunctive ... See full document
8
Sleep disturbances in Parkinson's disease patients and management options
... for patients with PD, there becomes a realization that sleep-related disorders are ubiquitous in this ...and disease clas- sification will rely on sleep-related subjective and objective ...cognitive ... See full document
9
Rasagiline in treatment of Parkinson’s disease
... neurodegenerative disease. In vitro, rasagiline has been shown to protect against a number of toxins such as 6- hydroxydopamine (6-OHDA), MPTP, beta-amyloid, and serum and nerve growth factor ...PD, ... See full document
10
Cognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study
... The second case was a 70-year-old married woman who exhibited wearing off and was depressed after her close friend passed away. Shortly thereafter, she had an injury to her arm caused by a fall 6 months prior to CBT. Her ... See full document
13
<p>Patient and physician perceptions of disease management in Parkinson’s disease: results from a US-based multicenter survey</p>
... of patients living with PD across a varied range of domains, including symptoms, 5–7 experience and expectations of therapy, 8–12 and psychosocial factors such as ...of disease management ... See full document
9
Study protocol of “CHAPS”: a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson’s Disease to improve the quality of care for individuals with Parkinson’s disease
... PD: Parkinson ’ s disease; CHAPS: Care coordination for health promotion and activities in Parkinson ’ s disease; VA: Veterans health administration; CCM: Chronic care model; ... See full document
13
A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease (ACCORD-PD)
... Go! To Sleep is a 6-week online, interactive CBT-I based program designed to foster better sleep habits and help participants implement cognitive behavioral therapy for insomnia strategies. Subjects were provided ... See full document
7
How to optimize the treatment of early stage Parkinson’s disease
... Patients were divided into 4 dose groups based on nom- inal levodopa dose at time of onset of dyskinesia (or study conclusion if no dyskinesia): Group 1, <400 mg/ day (n = 157); Group 2, 400 mg/day (n = 310); ... See full document
7
Potential sources of stem cells as a regenerative therapy for Parkinson's disease
... mations, or overgrowth in the transplanted primates in patients in an earlier stage of the disease. The authors found that grafted cells could survive, migrate, and induce behav- ioral recovery of ... See full document
9
Dance therapy for individuals with Parkinson's disease: improving quality of life
... The definitive beneficial ingredients of dance for improved HRQOL require elucidation, but dance programs may have multidimensional effects on self-assessment. The departure from the daily routine in everyday lives of ... See full document
9
Communication impairment in patients with Parkinson's disease: challenges and solutions
... The role of syntactic comprehension is crucial in normal language understanding. Successful processing of syntactic information allows people to extract meaning from utter- ances by combining words in a particular order ... See full document
11
Suicidal behavior among Turkish patients with Parkinson’s disease
... such patients should be followed ...onset, disease duration, major depression, and presence of a history of ICD behaviors in the Turkish PD ...PD patients whose disease started at earlier ages ... See full document
5
Epidemiology of Parkinson’s Disease in Africa
... for patients. In order to improve access to drugs for the disease, development of policies at a national level for dealing with chronic diseases as a whole is ... See full document
6
Related subjects